These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33044184)

  • 21. Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia.
    Quinlan P; Horvath A; Nordlund A; Wallin A; Svensson J
    Psychoneuroendocrinology; 2017 Dec; 86():169-175. PubMed ID: 28963885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.
    Skillbäck T; Delsing L; Synnergren J; Mattsson N; Janelidze S; Nägga K; Kilander L; Hicks R; Wimo A; Winblad B; Hansson O; Blennow K; Eriksdotter M; Zetterberg H
    Neurobiol Aging; 2017 Nov; 59():1-9. PubMed ID: 28779628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [P300 in mild cognitive impairment and in dementia].
    Egerházi A; Glaub T; Balla P; Berecz R; Degrell I
    Psychiatr Hung; 2008; 23(5):349-57. PubMed ID: 19129551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N200 and P300 component changes in Parkinson's disease: a meta-analysis.
    Xu H; Gu L; Zhang S; Wu Y; Wei X; Wang C; Xu Y; Guo Y
    Neurol Sci; 2022 Dec; 43(12):6719-6730. PubMed ID: 35982362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between cognitive functions and nitric oxide levels in patients with dementia.
    Sachdeva R; Babbar R; Puri V; Agarwal S; Krishana B
    Clin EEG Neurosci; 2011 Jul; 42(3):190-4. PubMed ID: 21870472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of cognitive impairment and mood disorder with event-related potential P300 in patients with cerebral small vessel diseases.
    Wang C; Gao J; Li M; Qi H; Zhao T; Zhang B; Zhou C; Fang S
    Neuro Endocrinol Lett; 2019 Dec; 40(7-8):333-341. PubMed ID: 32305050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
    Yang TT; Liu CG; Gao SC; Zhang Y; Wang PC
    Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological correlates of the P300 in patients with Alzheimer's disease.
    Lee MS; Lee SH; Moon EO; Moon YJ; Kim S; Kim SH; Jung IK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():62-9. PubMed ID: 22940475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
    Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
    Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of the P300 potential in cognitive impairment assessments after transient ischemic attack or minor stroke.
    Zhang Y; Xu H; Zhao Y; Zhang L; Zhang Y
    Neurol Res; 2021 Apr; 43(4):336-341. PubMed ID: 33443462
    [No Abstract]   [Full Text] [Related]  

  • 33. Associations of event-related brain potentials and Alzheimer's disease severity: A longitudinal study.
    Fruehwirt W; Dorffner G; Roberts S; Gerstgrasser M; Grossegger D; Schmidt R; Dal-Bianco P; Ransmayr G; Garn H; Waser M; Benke T
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():31-38. PubMed ID: 30582941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological deficits in vascular dementia vs Alzheimer's disease. Frontal lobe deficits prominent in vascular dementia.
    Kertesz A; Clydesdale S
    Arch Neurol; 1994 Dec; 51(12):1226-31. PubMed ID: 7986178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia.
    Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L
    Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using event-related potential P300 as an electrophysiological marker for differential diagnosis and to predict the progression of mild cognitive impairment: a meta-analysis.
    Jiang S; Qu C; Wang F; Liu Y; Qiao Z; Qiu X; Yang X; Yang Y
    Neurol Sci; 2015 Jul; 36(7):1105-12. PubMed ID: 25663086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical utility of the auditory P300 latency subcomponent event-related potential in preclinical diagnosis of patients with mild cognitive impairment and Alzheimer's disease.
    Howe AS; Bani-Fatemi A; De Luca V
    Brain Cogn; 2014 Apr; 86():64-74. PubMed ID: 24565814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Circulating Levels of Naturally Occurring Antibody to α-Synuclein in Parkinson's Disease Dementia, Alzheimer's Disease, and Vascular Dementia.
    Wang J; Zheng B; Yang S; Hu M; Wang JH
    Front Aging Neurosci; 2020; 12():571437. PubMed ID: 33088272
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting.
    Braverman ER; Chen TJ; Schoolfield J; Martinez-Pons M; Arcuri V; Varshavskiy M; Gordon CA; Mengucci J; Blum SH; Meshkin B; Downs BW; Blum K
    Adv Ther; 2006; 23(4):582-600. PubMed ID: 17050501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.